-
公开(公告)号：US08877717B2
公开(公告)日：2014-11-04
申请号：US12531035
申请日：2008-03-11
IPC分类号： A61K31/70 , A61K31/7004 , A61K36/48
CPC分类号： A61K36/48 , A61K31/7004
摘要： Novel and useful compositions derived from rooibos for treating diabetes are provided. The present invention is particularly concerned with the treatment of Type 2 diabetes. The invention provides a new use for aspalathin and rutin and compositions containing them for use in the prevention and treatment of diabetes. The invention provides an anti-diabetic agent, an anti-diabetic composition containing the anti-diabetic agent, a foodstuff or beverage containing the anti-diabetic agent, a method for preventing or treating diabetes or impaired glucose tolerance, and a method of decreasing blood glucose level. The anti-diabetic agent may be an extract from rooibos (Aspalathus spp.), aspalathin as such or in combination with rutin.
摘要翻译： 提供了衍生自用于治疗糖尿病的rooibos的新型和有用的组合物。 本发明特别涉及2型糖尿病的治疗。 本发明为用于预防和治疗糖尿病的芦丁蛋白和芦丁以及含有它们的组合物提供了新的用途。 本发明提供一种抗糖尿病药，含有抗糖尿病药的抗糖尿病药物组合物，含有抗糖尿病药的食品或饮料，糖尿病的预防或治疗或葡萄糖耐量降低的方法，以及减少血液的方法 葡萄糖水平。 抗糖尿病药物可以是来自罗非鱼（Aspalathus spp。），天冬酰胺酶本身或与芦丁组合的提取物。
-
公开(公告)号：US20120251643A1
公开(公告)日：2012-10-04
申请号：US13493614
申请日：2012-06-11
CPC分类号： A61K36/48 , A61K31/352 , A61K31/7048 , A61K36/00 , A61K2300/00
摘要： Novel and useful compositions derived from honeybush plant extract for treating diabetes are provided. It has been found that the plant extract of the present invention exhibit a superior antidiabetic effect when administered in an amount from about 1 milligram to about 5 milligrams, preferably to about 2.5 milligrams, per kilogram body weight.
摘要翻译： 提供了源自蜜蜂植物提取物治疗糖尿病的新颖有用的组合物。 已经发现，当以每千克体重约1毫克至约5毫克，优选至约2.5毫克的量施用时，本发明的植物提取物显示出优异的抗糖尿病作用。
-
公开(公告)号：US20110275579A1
公开(公告)日：2011-11-10
申请号：US12531035
申请日：2008-03-11
IPC分类号： A61K31/7048 , A61K31/7028 , A61P3/10 , C07H1/00
CPC分类号： A61K36/48 , A61K31/7004
摘要： Novel and useful compositions derived from rooibos for treating diabetes are provided. The present invention is particularly concerned with the treatment of Type 2 diabetes. The invention provides a new use for aspalathin and rutin and compositions containing them for use in the prevention and treatment of diabetes. The invention provides an antidiabetic agent, an anti-diabetic composition containing the anti-diabetic agent, a foodstuff or beverage containing the anti-diabetic agent, a method for preventing or treating diabetes or impaired glucose tolerance, and a method of decreasing blood glucose level. The anti-diabetic agent may be an extract from rooibos (Aspalathus spp.), aspalathin as such or in combination with rutin.
摘要翻译： 提供了衍生自用于治疗糖尿病的rooibos的新型和有用的组合物。 本发明特别涉及2型糖尿病的治疗。 本发明为用于预防和治疗糖尿病的芦丁蛋白和芦丁及其组合物提供了新的用途。 本发明提供一种抗糖尿病药，含有抗糖尿病药的抗糖尿病药物组合物，含有抗糖尿病药的食品或饮料，糖尿病的预防或治疗或糖耐量减低的方法，以及降低血糖水平的方法 。 抗糖尿病药物可以是来自罗非鱼（Aspalathus spp。），天冬酰胺酶本身或与芦丁组合的提取物。
-
公开(公告)号：US20110045108A1
公开(公告)日：2011-02-24
申请号：US12531028
申请日：2008-03-11
CPC分类号： A61K36/48 , A61K31/352 , A61K31/7048 , A61K36/00 , A61K2300/00
摘要： Novel and useful compositions derived from honeybush plant extract for treating diabetes are provided. It has been found that the plant extract of the present invention exhibit a superior antidiabetic effect when administered in an amount from about 1 milligram to about 5 milligrams, preferably to about 2.5 milligrams, per kilogram body weight.
摘要翻译： 提供了源自蜜蜂植物提取物治疗糖尿病的新颖有用的组合物。 已经发现，当以每千克体重约1毫克至约5毫克，优选至约2.5毫克的量施用时，本发明的植物提取物显示出优异的抗糖尿病作用。
-
公开(公告)号：US09221860B2
公开(公告)日：2015-12-29
申请号：US13878158
申请日：2010-10-07
申请人： Elizabeth Joubert , Stephen John Fey , Johan Louw , Trond Ulven , Rahul Tyagi
发明人： Elizabeth Joubert , Stephen John Fey , Johan Louw , Trond Ulven , Rahul Tyagi
CPC分类号： C07H15/203 , C07H15/18 , C07H15/26
摘要： There is provided an antidiabetic enolic glucoside of phenylpyruvic acid and derivatives thereof for use as medicaments, especially normoglycemic agents, i.e. for lowering blood glucose levels to normal levels in mammals that are obese, pre-diabetic or have diabetes, obesity and/or syndrome X. Hence the compounds of the present invention help to manage blood sugar levels, i.e. helping the body by balancing the blood sugar levels; helping to keep balanced blood glucose levels, particularly in humans with diabetes; aiding by enhancing the glucose uptake by the cells and by reducing sugar levels, thus improving or restoring the glucose tolerance; optimizing the glycemic response; normalizing the glucose tolerance.
摘要翻译： 提供苯丙酮酸及其衍生物的抗糖尿病烯醇葡糖苷及其衍生物，用作药物，尤其是正常血糖药，即将肥胖，糖尿病前期或糖尿病，肥胖和/或综合征X的哺乳动物血糖水平降低至正常水平 因此，本发明的化合物有助于控制血糖水平，即通过平衡血糖水平来帮助身体; 有助于保持平衡的血糖水平，特别是在患有糖尿病的人中; 通过增强细胞的葡萄糖摄取和降低糖水平，从而改善或恢复葡萄糖耐量来辅助; 优化血糖反应; 正常化葡萄糖耐量。
-
公开(公告)号：US20130310331A1
公开(公告)日：2013-11-21
申请号：US13878158
申请日：2010-10-07
申请人： Elizabeth Joubert , Stephen John Fey , Johan Louw , Trond Ulven , Rahul Tyagi
发明人： Elizabeth Joubert , Stephen John Fey , Johan Louw , Trond Ulven , Rahul Tyagi
CPC分类号： C07H15/203 , C07H15/18 , C07H15/26
摘要： There is provided an antidiabetic enolic glucoside of phenylpyruvic acid and derivatives thereof for use as medicaments, especially normoglycemic agents, i.e. for lowering blood glucose levels to normal levels in mammals that are obese, pre-diabetic or have diabetes, obesity and/or syndrome X. Hence the compounds of the present invention help to manage blood sugar levels, i.e. helping the body by balancing the blood sugar levels; helping to keep balanced blood glucose levels, particularly in humans with diabetes; aiding by enhancing the glucose uptake by the cells and by reducing sugar levels, thus improving or restoring the glucose tolerance; optimizing the glycemic response; normalizing the glucose tolerance.
摘要翻译： 提供了苯丙酮酸及其衍生物的抗糖尿病烯醇葡糖苷及其衍生物，用作药物，尤其是正常血糖药，即将肥胖，糖尿病前期或糖尿病，肥胖和/或综合征X的哺乳动物血糖水平降低至正常水平 因此，本发明的化合物有助于控制血糖水平，即通过平衡血糖水平来帮助身体; 有助于保持平衡的血糖水平，特别是在患有糖尿病的人中; 通过增强细胞的葡萄糖摄取和降低糖水平，从而改善或恢复葡萄糖耐量来辅助; 优化血糖反应; 正常化葡萄糖耐量。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.026 秒)
